SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Vieitez, P.
Right arrow Articles by Molina-Holgado, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vieitez, P.
Right arrow Articles by Molina-Holgado, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy

Paula Vieitez

Endocrinology Department. Ramon y Cajal Hospital, Madrid, Spain, vieitezp{at}yahoo.com

Oscar Gómez

Laboratory of Neuroinflammation, Experimental Neurology Department, Paraplegic National Hospital, Toledo, Spain, ogomezt{at}sescam.jccm.es

Esther R Uceda

Life Science Division, NASA Ames Research Centre, Moffet Field, CA, USA

María Eugenia Vera

Endocrinology Department. Ramon y Cajal Hospital, Madrid, Spain

Eduardo Molina-Holgado

Laboratory of Neuroinflammation, Experimental Neurology Department, Paraplegic National Hospital, Toledo, Spain

Introduction. Our objective was to evaluate the effect of blocking the renin-angiotensin system (RAS) on the expression of transforming growth factor-beta 1 (TGF-β1), platelet derived growth factor-B (PDGF-B), tumour necrosis factor-alpha (TNF-{alpha}) and vascular endothelial growth factor (VEGF) in diabetic kidney glomeruli.

Materials and Method. 1) Uninephrectomised streptozotocin induced diabetic rats were treated during eight months with vehicle (CD) or irbesartan (ID). Uninephrectomised non-diabetic rats were used as control group (ND). Protein urinary excretion and morphological renal damage were analysed. Glomerular expression of TGF-β1, PDGF-B, VEGF and TNF-{alpha} were evaluated by Western blot and Immunohistochemistry. 2) Isolated glomeruli of diabetic rats were incubated 24-hours in the presence of different doses of irbesartan. Glomerular expression of TGF-β1, PDGF-B,TNF-{alpha} and VEGF were determined by Western blot.

Results. ND and ID presented lower renal injury and proteinuria than CD (p<0.05). Glomerular expression of TGF-β1, PDGF-B,TNF-{alpha} and VEGF were similar in ND and ID, but lower than in CD (p<0.05). In addition, in isolated diabetic rat glomeruli, irbesartan reduced the content of all these factors.

Conclusion. Systemic and local administration of irbesartan lowers glomerular expression of TGF-β1, PDGF-B, VEGF and TNF-{alpha}.These data suggest that part of the effect of lowering the expression of these growth factors and cytokines is due to a direct blockade of glomerular RAS.

Key Words: angiotensin receptor blockers • diabetic nephropathy • glomeruli • growth factors • renin-angiotensin system

Journal of Renin-Angiotensin-Aldosterone System, Vol. 9, No. 2, 96-102 (2008)
DOI: 10.3317/jraas.2008.018
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement